跳至主要内容
临床试验/NCT05108025
NCT05108025进行中(未招募)2 期

A Study Of The Tolerability, Safety, And Efficacy Of DMT310 For The Treatment Of Acne Rosacea

Dermata Therapeutics1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2021年11月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
180
试验地点
1
主要终点
Efficacy as measured by lesion counts

研究概览

简要总结

The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder mixed with diluent in male and female patients with moderate to severe facial acne rosacea.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is male or non-pregnant female at least 18 years of age.
  • Clinical diagnosis of moderate to severe papulopustular acne rosacea as determined by:
  • Investigator's Global Assessment (IGA) at Randomization score of 3 or
  • Patient has at least 15 inflammatory lesions on the face
  • Patient is willing to apply the Investigational Product as directed
  • Patient is willing and able to comply with the protocol

排除标准

  • Patient is pregnant or planning to become pregnant Patient is taking a topical therapy on the face which may affect the patient's rosacea

研究组 & 干预措施

Study Treatment 1

Experimental

DMT310 Powder mixed with Hydrogen Peroxide

干预措施: Topical Powder (Drug)

Study Treatment 2

Experimental

Placebo powder mixed with Hydrogen Peroxide

干预措施: Placebo Topical Powder (Drug)

结局指标

主要结局

Efficacy as measured by lesion counts

时间窗: 12 Weeks

Inflammatory lesion counts

Efficacy as measured by Investigator Global Assessment (IGA)

时间窗: 12 Weeks

IGA Scale: 0 Clear No papules and/or pustules 1. Almost Clear Rare papules and/or pustules 2. Mild Few papules and/or pustules 3. Moderate Pronounced number of papules and/or pustules (but less than numerous papules and/or pustules) 4. Severe Numerous papules and/or pustules, occasionally with confluent areas of inflamed lesions

次要结局

  • Incidence of adverse events as a measure of safety and tolerability(12 Weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

DMT310-005 Topical in the Treatment of Acne Rosacea | 临床试验